210 related articles for article (PubMed ID: 20541589)
1. Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
Brothers HM; Marchalant Y; Wenk GL
Neurosci Lett; 2010 Aug; 480(2):97-100. PubMed ID: 20541589
[TBL] [Abstract][Full Text] [Related]
2. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
Gołembiowska K; Wardas J; Noworyta-Sokołowska K; Kamińska K; Górska A
Neurotox Res; 2013 Jul; 24(1):29-40. PubMed ID: 23296550
[TBL] [Abstract][Full Text] [Related]
3. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat.
Rosi S; Vazdarjanova A; Ramirez-Amaya V; Worley PF; Barnes CA; Wenk GL
Neuroscience; 2006 Nov; 142(4):1303-15. PubMed ID: 16989956
[TBL] [Abstract][Full Text] [Related]
4. Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.
Madeira MH; Boia R; Ambrósio AF; Santiago AR
Mediators Inflamm; 2017; 2017():4761081. PubMed ID: 28250576
[TBL] [Abstract][Full Text] [Related]
5. Treatment with A
Boia R; Elvas F; Madeira MH; Aires ID; Rodrigues-Neves AC; Tralhão P; Szabó EC; Baqi Y; Müller CE; Tomé ÂR; Cunha RA; Ambrósio AF; Santiago AR
Cell Death Dis; 2017 Oct; 8(10):e3065. PubMed ID: 28981089
[TBL] [Abstract][Full Text] [Related]
6. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.
Quarta D; Ferré S; Solinas M; You ZB; Hockemeyer J; Popoli P; Goldberg SR
J Neurochem; 2004 Mar; 88(5):1151-8. PubMed ID: 15009670
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases.
Boia R; Ambrósio AF; Santiago AR
Ophthalmic Res; 2016; 55(4):212-8. PubMed ID: 26959995
[TBL] [Abstract][Full Text] [Related]
8. Anthocyanins Improve Hippocampus-Dependent Memory Function and Prevent Neurodegeneration via JNK/Akt/GSK3β Signaling in LPS-Treated Adult Mice.
Khan MS; Ali T; Kim MW; Jo MH; Chung JI; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):671-687. PubMed ID: 29779175
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease.
Rosi S; Pert CB; Ruff MR; McGann-Gramling K; Wenk GL
Neuroscience; 2005; 134(2):671-6. PubMed ID: 15979806
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation regulates microglial responses to tissue damage in vivo.
Gyoneva S; Davalos D; Biswas D; Swanger SA; Garnier-Amblard E; Loth F; Akassoglou K; Traynelis SF
Glia; 2014 Aug; 62(8):1345-60. PubMed ID: 24807189
[TBL] [Abstract][Full Text] [Related]
11. The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A
Lopes JP; Pliássova A; Cunha RA
Biochem Pharmacol; 2019 Aug; 166():313-321. PubMed ID: 31199895
[TBL] [Abstract][Full Text] [Related]
12. Adora2A downregulation promotes caffeine neuroprotective effect against LPS-induced neuroinflammation in the hippocampus.
Lemes Dos Santos Sanna P; Bernardes Carvalho L; Cristina Dos Santos Afonso C; de Carvalho K; Aires R; Souza J; Rodrigues Ferreira M; Birbrair A; Martha Bernardi M; Latini A; Foganholi da Silva RA
Brain Res; 2024 Jun; 1833():148866. PubMed ID: 38494098
[TBL] [Abstract][Full Text] [Related]
13. Caffeine modulates TNF-alpha production by cord blood monocytes: the role of adenosine receptors.
Chavez-Valdez R; Wills-Karp M; Ahlawat R; Cristofalo EA; Nathan A; Gauda EB
Pediatr Res; 2009 Feb; 65(2):203-8. PubMed ID: 19047957
[TBL] [Abstract][Full Text] [Related]
14. IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation.
Sun J; Zhang S; Zhang X; Zhang X; Dong H; Qian Y
J Neuroinflammation; 2015 Sep; 12():165. PubMed ID: 26373740
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction.
Rebola N; Simões AP; Canas PM; Tomé AR; Andrade GM; Barry CE; Agostinho PM; Lynch MA; Cunha RA
J Neurochem; 2011 Apr; 117(1):100-11. PubMed ID: 21235574
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression.
Rosi S; Ramirez-Amaya V; Vazdarjanova A; Worley PF; Barnes CA; Wenk GL
J Neurosci; 2005 Jan; 25(3):723-31. PubMed ID: 15659610
[TBL] [Abstract][Full Text] [Related]
17. A noradrenergic lesion aggravates the effects of systemic inflammation on the hippocampus of aged rats.
Bharani KL; Derex R; Granholm AC; Ledreux A
PLoS One; 2017; 12(12):e0189821. PubMed ID: 29261743
[TBL] [Abstract][Full Text] [Related]
18. Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury.
Madeira MH; Boia R; Elvas F; Martins T; Cunha RA; Ambrósio AF; Santiago AR
Transl Res; 2016 Mar; 169():112-28. PubMed ID: 26685039
[TBL] [Abstract][Full Text] [Related]
19. Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism.
George J; Gonçalves FQ; Cristóvão G; Rodrigues L; Meyer Fernandes JR; Gonçalves T; Cunha RA; Gomes CA
Glia; 2015 Sep; 63(9):1636-45. PubMed ID: 25847308
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease.
Schwarzschild MA; Xu K; Oztas E; Petzer JP; Castagnoli K; Castagnoli N; Chen JF
Neurology; 2003 Dec; 61(11 Suppl 6):S55-61. PubMed ID: 14663012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]